dipyridamole has been researched along with Embolism, Fat in 2 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
Embolism, Fat: Blocking of a blood vessel by fat deposits in the circulation. It is often seen after fractures of large bones or after administration of CORTICOSTEROIDS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Williams, IM | 1 |
| Merrillees, NC | 1 |
| Robinson, PM | 1 |
| Wehner, W | 1 |
2 other studies available for dipyridamole and Embolism, Fat
| Article | Year |
|---|---|
Microembolism and the visual system. Part II: the consequence of emboli in the microcirculation of nervous tissue, especially that comprizing the visual system.
Topics: Animals; Cardiopulmonary Bypass; Carotid Artery Thrombosis; Dipyridamole; Dogs; Embolism; Embolism, | 1975 |
[Causes of the heart-circulatory changes in experimental fat embolism and their therapeutic consequences].
Topics: Animals; Arteries; Blood Pressure; Cardiovascular System; Cats; Coronary Vessels; Dipyridamole; Elec | 1967 |